The present invention relates to a novel Pediococcus genus microorganism
and more particularly, Pediococcus pentosaceus EROM101 (KCCM-10517)
originated from human intestines having immune enhancement, anticancer
and antiviral activities and a use thereof. Due to its excellent immune
enhancement, anticancer and antimicrobial activities by activating
macrophages/spleen cells and inducing gut immunity, the Pediococcus
pentosaceus EROM101 of the present invention can be effectively used for
the production of various products such as immune enhancement agent,
anticancer agent, antimicrobial agent, food additive, intestinal
function-controlling agent, live bacterial agent, feed additive and other
fermented products.